Roche: positive data presented on Ocrevus

(CercleFinance.com) - Roche announced today that new Ocrevus (ocrelizumab) data will be presented at the 34th Congress of the European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMS) from 10 October to 12 October in Berlin, Germany.


"OCREVUS (ocrelizumab) data show early initiation of treatment reduces disability progression over five years in relapsing and primary progressive multiple sclerosis," Roche said.


Copyright (c) 2018 CercleFinance.com. All rights reserved.